Skip to main content

Advertisement

SpringerLink
Log in

Expression of multidrug resistance-associated ABC transporters in B-CLL is independent of ZAP70 status

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

To assess whether the poor prognosis of ZAP70-positive B-cell chronic lymphocytic leukemia (CLL) is associated with the overexpression of ABC transporter genes that are responsible for pleiotropic drug resistance.

Materials and methods

The transcript level of ten drug transporters was analyzed using semiquantitative and quantitative RT-PCR in control hematopoietic cells, in 41 CLL patient samples and in 5 lymphoma cell lines. ZAP70 status was determined by immunoblotting.

Results

Of all analyzed transporters, MDR1, MDR2, MRP1, MRP4, MRP5, and MRP7 were expressed at a significantly higher level in B lymphocytes when compared with other hematopoietic cells in peripheral blood. A subgroup of 41 CLL patient samples showed similar or higher expression of these genes than control B cells, and CLL cells exhibited high expression when compared with multiple lymphoma cell lines. No significant correlation between ZAP70 expression and ABC transporter expression was observed.

Conclusion

The ZAP70 status is independent of the multidrug resistance phenotype in CLL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Andreadis C, Gimotty PA, Wahl P, Hammond R, Houldsworth J, Schuster SJ, Rebbeck TR (2007) Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma. Blood 109:3409–3416

    Article  CAS  PubMed  Google Scholar 

  • Bogner C, Sandherr M, Perker M, Weick K, Ringshausen I, Peschel C, Decker T (2006) Cyclin E but not bcl-2, bax or mcl-1 is differentially expressed in ZAP 70-positive and ZAP 70-negative B-CLL cells. Ann Hematol 85:458–462

    Article  CAS  PubMed  Google Scholar 

  • Bosanquet AG, Johnson SA, Richards SM (1999) Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay. Br J Haematol 106:71–77

    Article  CAS  PubMed  Google Scholar 

  • Chaudhary PM, Roninson IB (1991) Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85–94

    Article  CAS  PubMed  Google Scholar 

  • Chen L, Widhopf G, Huynh L, Rassenti L, Rai KR, Weiss A, Kipps TJ (2002) Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood 100:4609–4614

    Article  CAS  PubMed  Google Scholar 

  • Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marce S, Lopez-Guillermo A, Campo E, Montserrat E (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 348:1764–1775

    Article  CAS  PubMed  Google Scholar 

  • Damle RN, Ghiotto F, Valetto A, Albesiano E, Fais F, Yan XJ, Sison CP, Allen SL, Kolitz J, Schulman P, Vinciguerra VP, Budde P, Frey J, Rai KR, Ferrarini M, Chiorazzi N (2002) B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 99:4087–4093

    Article  CAS  PubMed  Google Scholar 

  • Decker T, Oelsner M, Kreitman RJ, Salvatore G, Wang QC, Pastan I, Peschel C, Licht T (2004) Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins. Blood 103:2718–2726

    Article  CAS  PubMed  Google Scholar 

  • Del Principe MI, Del Poeta G, Buccisano F, Maurillo L, Venditti A, Zucchetto A, Marini R, Niscola P, Consalvo MA, Mazzone C, Ottaviani L, Panetta P, Bruno A, Bomben R, Suppo G, Degan M, Gattei V, de Fabritiis P, Cantonetti M, Lo Coco F, Del Principe D, Amadori S (2006) Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood 108:853–861

    Article  CAS  PubMed  Google Scholar 

  • Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84:265–269

    Article  CAS  PubMed  Google Scholar 

  • Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM (1989) Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81:116–124

    Article  CAS  PubMed  Google Scholar 

  • Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48–58

    Article  CAS  PubMed  Google Scholar 

  • Guillaume N, Gouilleux-Gruart V, Claisse JF, Troussard X, Lepelley P, Damaj G, Royer B, Garidi R, Lefrere JJ (2007) Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70/CD38 expression in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 48:1556–1560

    Article  CAS  PubMed  Google Scholar 

  • Guo Y, Kotova E, Chen ZS, Lee K, Hopper-Borge E, Belinsky MG, Kruh GD (2003) MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2′, 3′-dideoxycytidine and 9′-(2′-phosphonylmethoxyethyl)adenine. J Biol Chem 278:29509–29514

    Article  CAS  PubMed  Google Scholar 

  • Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) updating the National Cancer Institute-Working Group (NCI-WG) 1996 guidelines. Blood 111:5446–5456

    Article  CAS  PubMed  Google Scholar 

  • Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848–1854

    CAS  PubMed  Google Scholar 

  • Herweijer H, Sonneveld P, Baas F, Nooter K (1990) Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J Natl Cancer Inst 82:1133–1140

    Article  CAS  PubMed  Google Scholar 

  • Jerkeman M, Anderson H, Dictor M, Kvaloy S, Akerman M, Cavallin-Stahl E (2004) Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma—a Nordic Lymphoma Group study. Ann Hematol 83:414–419

    Article  CAS  PubMed  Google Scholar 

  • Matthews C, Catherwood MA, Larkin AM, Clynes M, Morris TC, Alexander HD (2006) MDR-1, but not MDR-3 gene expression, is associated with unmutated IgVH genes and poor prognosis chromosomal aberrations in chronic lymphocytic leukemia. Leuk Lymphoma 47:2308–2313

    Article  CAS  PubMed  Google Scholar 

  • Molina-Arcas M, Bellosillo B, Casado FJ, Montserrat E, Gil J, Colomer D, Pastor-Anglada M (2003) Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia. Blood 101:2328–2334

    Article  CAS  PubMed  Google Scholar 

  • Nooter K, Sonneveld P, Janssen A, Oostrum R, Boersma T, Herweijer H, Valerio D, Hagemeijer A, Baas F (1990) Expression of the mdr3 gene in prolymphocytic leukemia: association with cyclosporin-A-induced increase in drug accumulation. Int J Cancer 45:626–631

    Article  CAS  PubMed  Google Scholar 

  • Ohsawa M, Ikura Y, Fukushima H, Shirai N, Sugama Y, Suekane T, Hirayama M, Hino M, Ueda M (2005) Immunohistochemical expression of multidrug resistance proteins as a predictor of poor response to chemotherapy and prognosis in patients with nodal diffuse large B-cell lymphoma. Oncology 68:422–431

    Article  CAS  PubMed  Google Scholar 

  • Pepper C, Thomas A, Hoy T, Bentley P (1999) Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones. Br J Haematol 104:581–588

    Article  CAS  PubMed  Google Scholar 

  • Ritzel MW, Ng AM, Yao SY, Graham K, Loewen SK, Smith KM, Ritzel RG, Mowles DA, Carpenter P, Chen XZ, Karpinski E, Hyde RJ, Baldwin SA, Cass CE, Young JD (2001) Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol Chem 276:2914–2927

    Article  CAS  PubMed  Google Scholar 

  • Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, Yang L, Pickeral OK, Rassenti LZ, Powell J, Botstein D, Byrd JC, Grever MR, Cheson BD, Chiorazzi N, Wilson WH, Kipps TJ, Brown PO, Staudt LM (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194:1639–1647

    Article  CAS  PubMed  Google Scholar 

  • Schaich M, Soucek S, Thiede C, Ehninger G, Illmer T (2005) MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia. Br J Haematol 128:324–332

    Article  CAS  PubMed  Google Scholar 

  • Shen DW, Cardarelli C, Hwang J, Cornwell M, Richert N, Ishii S, Pastan I, Gottesman MM (1986) Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. J Biol Chem 261:7762–7770

    CAS  PubMed  Google Scholar 

  • Sonneveld P, Nooter K, Burghouts JT, Herweijer H, Adriaansen HJ, van Dongen JJ (1992) High expression of the mdr3 multidrug-resistance gene in advanced-stage chronic lymphocytic leukemia. Blood 79:1496–1500

    CAS  PubMed  Google Scholar 

  • Tangye SG, Raison RL (1997) Human cytokines suppress apoptosis of leukaemic CD5+ B cells and preserve expression of bcl-2. Immunol Cell Biol 75:127–135

    Article  CAS  PubMed  Google Scholar 

  • Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101:4944–4951

    Article  CAS  PubMed  Google Scholar 

  • Zent CS, Call TG, Hogan WJ, Shanafelt TD, Kay NE (2006) Update on risk-stratified management for chronic lymphocytic leukemia. Leuk Lymphoma 47:1738–1746

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the German José Carreras Leukemia Foundation (Project R04/17 to T. Licht and U. Keller). We are grateful to M. Gottesman, National Cancer Institute, Bethesda, USA, for providing the drug-resistant cell lines KB-3-1 and KB-8-5. We also would like to thank T. Schuster, Institute for Medical Statistics and Epidemiology, Technische Universität München, Munich, Germany, for help with statistical analysis.

Conflict of interest statement

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

  1. III Medical Department, Technische Universität München, Ismaninger Street 15, 81675, Munich, Germany

    Alexander Hoellein, Thomas Decker, Christian Bogner, Madlen Oelsner, Stefanie Hauswald, Christian Peschel, Ulrich Keller & Thomas Licht

  2. HELIOS Schlossbergklinik, Oberstaufen, Germany

    Thomas Licht

Authors
  1. Alexander Hoellein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Decker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christian Bogner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Madlen Oelsner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stefanie Hauswald
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christian Peschel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ulrich Keller
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Thomas Licht
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrich Keller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoellein, A., Decker, T., Bogner, C. et al. Expression of multidrug resistance-associated ABC transporters in B-CLL is independent of ZAP70 status. J Cancer Res Clin Oncol 136, 403–410 (2010). https://doi.org/10.1007/s00432-009-0670-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-009-0670-9

Keywords

Search

Navigation